Feb 11, 2020 - Eli Lilly's (LLY) Alzheimer's disease drug, solanezumab, fails to meet primary endpoint in a phase II/III investigator-led study.
Feb 12, 2020 - Koninklijke Vopak NV (OTCPK:VOPKF) Q4 2019 Earnings Conference Call February 12, 2020, 05:00 ET Company Participants Laurens de Graaf - Head, IR Eelco Hoekstra - Chairman & CEO Gerard Paulides - C
Feb 14, 2020 - Barco NV (OTCPK:BCNAF) Q4 2019 Earnings Conference Call February 13, 2019 03:00 AM ET Company Participants Carl Vanden Bussche - Vice President of Investor Relations Jan De Witte - Chief Executive Off
Feb 14, 2020 -
Nov 25, 2019 - Novartis (NVS) set to acquire The Medicines Company and add a promising candidate to its cardiovascular pipeline.
Nov 26, 2019 - Here are four stocks that boast promising prospects and are most likely to be takeout targets.
Nov 27, 2019 - Global Blood's (GBT) Oxbryta wins the FDA nod to address sickle cell disease in patients aged 12 years and above. The approval comes three months ahead of schedule.
Nov 28, 2019 - IMO 2020 sulfur regulation goes into effect January 1, 2020.Frontline has chosen a scrubber strategy.Euronav has chosen a pre-purchase at bulk prices and store compliant fuel.The most economical strat
Dec 02, 2019 - Novartis's purchase comes with investigational cardiovascular drug inclisiran, a competitor with potential to dethrone Amgen's already embattled Repatha.
Dec 06, 2019 - Regeneron (REGN) announces positive top-line data from a phase II study on rare blood disorder drug.